Financials Transcenta Holding Limited

Equities

6628

KYG9005B1041

Pharmaceuticals

Market Closed - Hong Kong S.E. 04:08:20 2024-04-26 am EDT 5-day change 1st Jan Change
1.78 HKD +1.71% Intraday chart for Transcenta Holding Limited +5.95% -50.42%

Valuation

Fiscal Period: December 2021 2022 2023 2024 2025 2026
Capitalization 1 - 1,150 1,359 669.9 - -
Enterprise Value (EV) 1 - 665.7 1,173 892.3 214.5 689.9
P/E ratio - -2.91 x -2.86 x -2.17 x -1.5 x -1.4 x
Yield - - - - - -
Capitalization / Revenue - 11.3 x 25.2 x 4.15 x 3.8 x 8.78 x
EV / Revenue - 6.53 x 21.8 x 5.53 x 1.22 x 9.04 x
EV / EBITDA - -1.67 x -2.65 x -3.2 x -0.58 x -1.5 x
EV / FCF - -2.09 x - -0.93 x -0.39 x -1.74 x
FCF Yield - -47.8% - -108% -255% -57.4%
Price to Book - - - - - -
Nbr of stocks (in thousands) - 419,920 416,576 406,579 - -
Reference price 2 7.496 2.738 3.263 1.648 1.648 1.648
Announcement Date 3/21/22 3/30/23 3/27/24 - - -
1CNY in Million2CNY
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2021 2022 2023 2024 2025 2026
Net sales 1 50.24 101.9 53.85 161.4 176.3 76.29
EBITDA 1 -434.4 -398.5 -442.1 -278.9 -369.2 -459.8
EBIT 1 -480.2 -442.3 -485 -323.7 -455.3 -437.6
Operating Margin -955.81% -434.13% -900.75% -200.54% -258.3% -573.63%
Earnings before Tax (EBT) 1 - -407 -462.8 -308.6 -457.4 -437.8
Net income 1 - -406.7 -462.6 -308.6 -457.4 -480.5
Net margin - -399.19% -859.01% -191.18% -259.5% -629.82%
EPS 2 - -0.9400 -1.140 -0.7600 -1.095 -1.180
Free Cash Flow 1 - -318 - -964 -547 -396
FCF margin - -312.09% - -597.15% -310.32% -519.05%
FCF Conversion (EBITDA) - - - - - -
FCF Conversion (Net income) - - - - - -
Dividend per Share 2 - - - - - -
Announcement Date 3/21/22 3/30/23 3/27/24 - - -
1CNY in Million2CNY
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2021 S2 2022 S1 2022 S2 2023 S1 2023 S2 2024 S1 2024 S2
Net sales 1 23.56 - 80.13 36.08 17.76 26.66 134.8
EBITDA - - - - - - -
EBIT 1 -275.6 - -216.2 -255.8 -229.3 -196.7 -127.1
Operating Margin -1,170.02% - -269.8% -708.85% -1,290.54% -737.89% -94.27%
Earnings before Tax (EBT) - - - - - - -
Net income - -204.1 - - - - -
Net margin - - - - - - -
EPS 2 - -0.4700 - -0.5800 -0.5600 -0.4600 -0.2900
Dividend per Share - - - - - - -
Announcement Date 3/21/22 8/29/22 3/30/23 8/22/23 3/27/24 - -
1CNY in Million2CNY
Estimates

Balance Sheet Analysis

Fiscal Period: December 2021 2022 2023 2024 2025 2026
Net Debt 1 - - - 222 - 19.9
Net Cash position 1 857 484 186 - 455 -
Leverage (Debt/EBITDA) - - - -0.7972 x - -0.0434 x
Free Cash Flow 1 - -318 - -964 -547 -396
ROE (net income / shareholders' equity) - -23.7% -35% -822% - -
ROA (Net income/ Total Assets) - -17.4% -32.1% -15.8% -9.4% -
Assets 1 - 2,340 1,440 1,953 4,866 -
Book Value Per Share - - - - - -
Cash Flow per Share - - - - - -
Capex 1 - 22.2 - 426 80 80
Capex / Sales - 21.77% - 263.88% 45.38% 104.86%
Announcement Date 3/21/22 3/30/23 3/27/24 - - -
1CNY in Million
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
2
Last Close Price
1.648 CNY
Average target price
7.58 CNY
Spread / Average Target
+360.04%
Consensus
  1. Stock Market
  2. Equities
  3. 6628 Stock
  4. Financials Transcenta Holding Limited